Skip to content
Π. Τσαλδάρη 5, Μαρούσι - Τ.: 2106142511

Σοφ. Βενιζέλου 114, Χαλάνδρι - Τ.: 2106719422

spyrigas@gmail.com
Facebook page opens in new windowX page opens in new windowInstagram page opens in new window
Cardiometaboliko – Σπύρος Ρήγας
Σπύρος Ρήγας – Ειδικός Παθολόγος
Cardiometaboliko - Σπύρος ΡήγαςCardiometaboliko - Σπύρος Ρήγας
  • Αρχική
    • Βιογραφικό Σπύρου Ρήγα
  • Καρδιομεταβολικός Κίνδυνος
    • Σακχαρώδης Διαβήτης
    • Διαταραχές Λιπιδίων
    • Μεταβολικό Σύνδρομο
    • Ηπατολογικό
    • Υπέρταση
    • Παχυσαρκία
    • Φυσική Άσκηση
  • Υπηρεσίες
  • Νέα
  • Επικοινωνία
Search:
Search
  • Αρχική
    • Βιογραφικό Σπύρου Ρήγα
  • Καρδιομεταβολικός Κίνδυνος
    • Σακχαρώδης Διαβήτης
    • Διαταραχές Λιπιδίων
    • Μεταβολικό Σύνδρομο
    • Ηπατολογικό
    • Υπέρταση
    • Παχυσαρκία
    • Φυσική Άσκηση
  • Υπηρεσίες
  • Νέα
  • Επικοινωνία

Monthly Archives: November 2020

You are here:
  1. Home
  2. 2020
  3. November

Metformin Improves Most Outcomes for T2D During Pregnancy

UncategorizedBy CarDio-AdMin24/11/2020Leave a comment

Women with type 2 diabetes who take metformin during pregnancy to control their blood glucose levels experience a range of benefits, including reduced weight gain, reduced insulin doses, and fewer large for gestational age babies, suggest the results of a randomized controlled trial.

Rapid COVID-19 breath test can help differentiate between other infections

UncategorizedBy CarDio-AdMin24/11/2020Leave a comment

With the onset of influenza season and the potential overlap of influenza and COVID-19 symptoms, there is a need to be able to quickly differentiate between the two viruses to ensure that patients are appropriately managed.

First SGLT1/2 Inhibitor Shows ‘Spectacular’ Phase 3 Safety and Efficacy in T2D

UncategorizedBy CarDio-AdMin24/11/2020Leave a comment

Sotagliflozin, a novel type of sodium-glucose cotransporter inhibitor, showed the diverse benefits this drug class provides along with some new twists in a pair of international pivotal trials that together enrolled nearly 12,000 patients with type 2 diabetes

Can Autoimmune Antibodies Explain Blood Clots in COVID-19?

UncategorizedBy CarDio-AdMin23/11/2020Leave a comment

Caption: Illustration showing a blood vessel with a platelet clot (yellow). Red blood cells (red), neutrophils (purple), and Y-shaped antibodies called aPL (white) circulate through the vessel. Credit: Stephanie King/Michigan Medicine For people with severe COVID-19, one of the most troubling complications is abnormal blood clotting that puts them at risk of having a debilitating…

Performing a Nasopharyngeal and Oropharyngeal Swab

UncategorizedBy CarDio-AdMin20/11/2020Leave a comment

https://youtu.be/syXd7kgLSN8

How children are tested for COVID-19

UncategorizedBy CarDio-AdMin20/11/2020Leave a comment

https://youtu.be/ndMrEMyRgQM

Collection of Nasopharyngeal Specimens with the Swab Technique

UncategorizedBy CarDio-AdMin20/11/2020Leave a comment

https://youtu.be/DVJNWefmHjE

Caption: Atomic-level structure of the spike protein of the virus that causes COVID-19. Credit: McLellan Lab, University of Texas at Austin

UncategorizedBy CarDio-AdMin13/11/2020Leave a comment

Two Studies Show COVID-19 Antibodies Persist for Months

UncategorizedBy CarDio-AdMin13/11/2020Leave a comment

More than 8 million people in the United States have now tested positive for COVID-19. For those who’ve recovered, many wonder if fending off SARS-CoV-2—the coronavirus that causes COVID-19—one time means their immune systems will protect them from reinfection. And, if so, how long will this “acquired immunity” last? The early data brought hope that…

Caption: Artistic rendering of SARS-CoV-2 virus (orange) covered with antibodies (white), generated by an immune B cell (gray) at the bottom left. Credit: iStock/selvanegra

UncategorizedBy CarDio-AdMin13/11/2020Leave a comment
→12→
Cardiometaboliko - Σπύρος Ρήγας

Ⓒ cardiometaboliko.gr 2019. All rights reserved.

Go to Top